Trial · NCT02449239
Results by group16
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 16 of 16
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Complete Response Rate at 3 Months | Vicinium | 39 | 95% Confidence Interval 29 to 49 | percentage of participants | |
| Duration of Complete Response | Vicinium | 273.0 | 95% Confidence Interval 155.0 to NA | days | |
| Event-free Survival | Vicinium | 90.5 | 95% Confidence Interval 81.0 to 179.0 | days | |
| Complete Response Rate at 6, 9, 12, 15, 18, 21, 24 Months | Vicinium | 6 months | 28 | 95% Confidence Interval 19 to 38 | percentage of participants |
| Complete Response Rate at 6, 9, 12, 15, 18, 21, 24 Months | Vicinium | 9 months | 19 | 95% Confidence Interval 12 to 29 | percentage of participants |
| Complete Response Rate at 6, 9, 12, 15, 18, 21, 24 Months | Vicinium | 12 months | 16 | 95% Confidence Interval 9 to 25 | percentage of participants |
| Complete Response Rate at 6, 9, 12, 15, 18, 21, 24 Months | Vicinium | 15 months | 14 | 95% Confidence Interval 8 to 23 | percentage of participants |
| Complete Response Rate at 6, 9, 12, 15, 18, 21, 24 Months | Vicinium | 18 months | 14 | 95% Confidence Interval 8 to 23 | percentage of participants |
| Complete Response Rate at 6, 9, 12, 15, 18, 21, 24 Months | Vicinium | 21 months | 13 | 95% Confidence Interval 7 to 21 | percentage of participants |
| Complete Response Rate at 6, 9, 12, 15, 18, 21, 24 Months | Vicinium | 24 months | 12 | 95% Confidence Interval 6 to 20 | percentage of participants |
| Time to Cystectomy | Vicinium | NA | 95% Confidence Interval NA to NA | days | |
| Time to Disease Recurrence | Vicinium | 436.0 | 95% Confidence Interval 170.0 to NA | days | |
| Progression-free Survival | Vicinium | NA | 95% Confidence Interval NA to NA | days | |
| Overall Survival | Vicinium | NA | 95% Confidence Interval NA to NA | days | |
| Number of Participants Who Experienced an Adverse Event (AE) | Vicinium | 123 | Participants | ||
| Number of Participants That Discontinued Study Treatment Due to an AE | Vicinium | 4 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02449239/results